This article looks at how the MAPPs assay works, how it integrates with other immunogenicity assays, and just how it can be flipped to help in vaccine design.
Campbell Bunce
Advertisement
Campbell Bunce is Chief Scientific Officer (CSO) and Cambridge Site Head at Abzena.
Articles by Campbell Bunce
Advertisement
Latest Updated Articles
Advertisement
Advertisement
